---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-009163"
form_type: "8-K"
ticker: "NXTC"
cik: "0001661059"
company_name: "NextCure, Inc."
filed_at: "2025-07-10T23:59:59+00:00"
generated_at: "2026-05-18T08:46:21.140958+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# NextCure approves 1-for-12 reverse stock split effective July 14, 2025

## Summary
- Board approved 1:12 reverse stock split; effective July 14, 2025 with split-adjusted trading at market open.
- Every 12 shares convert into 1 share; fractional shares paid in cash based on prior day's closing price.
- Outstanding equity awards, incentive plans, and exercise prices adjusted proportionally to the split.
- No change to common stock par value; trading symbol remains NXTC on Nasdaq.

## SEC filing metadata
- accession: 0001558370-25-009163
- form_type: 8-K
- ticker: NXTC
- cik: 0001661059
- company_name: NextCure, Inc.
- filed_at: 2025-07-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661059/000155837025009163/0001558370-25-009163-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661059/000155837025009163/nxtc-20250710x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-009163
- JSON: https://secwatch.observer/filing/0001558370-25-009163.json
- Plain text: https://secwatch.observer/filing/0001558370-25-009163.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.